Trial intelligence / Profile preview

Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis

NCT07557966Completed

Sponsor
Tanta University
Start
Jan 2022
Primary completion
Dec 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Trial of fluconazole in fungal keratitis (FK) (2 arms), sponsored by Tanta University. Primary endpoint: Best-corrected visual acuity up to 6 weeks. Started Jan 2022; status: completed.

02

Drugs

fluconazole
03

Conditions

fungal keratitis (FK)

Beyond the preview

Go deeper on NCT07557966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07557966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call